Media Resources

2017

Pharmaceutical Promotion in Medical and Pharmacy Education in The Netherlands: Readiness for Curriculum Change

HAI & Global Snakebite Initiative Applaud WHO’s Adoption of Snakebite Envenoming as Top-level Neglected Tropical Disease

Proposed Changes to EMA’s Access to Documents Policy Fall Short on Proactive Disclosure

Joint Letter to World Health Assembly Delegates | We must delink research and development costs from cancer medicine prices

2016 Annual Report & Financial Statements

Report | The Sun Shines on Europe: transparency of financial relationships in the healthcare sector

ACCISS Study Report | Access to Insulin: Current Challenges and Constraints

Position Statement: TACD Positive Consumer Agenda – New Rules for the Global Economy

Media Release: Health Action International start een publiekscampagne tegen stijgende medicijnprijzen

Media Release: Soaring Medicine Prices the Target Of New Public Campaign Ahead Of 15 March Election

Media Statement: European Parliament Hits Target in Recommendations for Improving Access to Medicines

Media Release: European Public Health Advocates Demand Greater Public Returns From European Commission’s Research and Development Programme, Horizon 2020

Joint Submission to European Commission Public Consultation on Horizon 2020

2016

Medicines Policy in Moldova

Fact or Fiction? What Healthcare Professionals Need to Know about Pharmaceutical Marketing

Prices and Availability of Locally Produced and Imported Medicines in Ethiopia

Prices and Availability of Locally Produced and Imported Medicines in Tanzania

Health Systems Advocacy Partnership: Fact Sheet

Press Release: Health Action International Receives €460,000 Grant from Dutch Ministry of Foreign Affairs to Fight Snakebite Death & Disability in Sub-Saharan Africa

Press Release: Health Action International Launches Educational Guide to Help EU Healthcare Students & Professionals Counter Ill Effects of Pharmaceutical Marketing

Joint Letter: Civil Society Urges US Secretary Burwell to Expand Access to Patented Cancer Drugs in Developing Countries

Press Release: Report Reveals Danger Of TTIP Locking Europe & Us Into Higher Drug Prices, Failed Pharma Innovation Model

Fact or Fiction: What Healthcare Professionals Need to Know about Pharmaceutical Marketing in the European Union

56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry

Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines

Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication

HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure

Snakebite: Call for urgent global action to end death & suffering

HAI, KEI & STOPAIDS Statement on the WHO Consultative Expert Working Group on R&D